Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer
This study has been terminated.
Varian Medical Systems
Information provided by (Responsible Party):
Quynh-Thu Le, Stanford University
First received: November 9, 2009
Last updated: April 6, 2012
Last verified: April 2012
To determine if a new optical system that can track a patient's movement during treatment can be used to measure motion and allow for motion adjustments in order to decrease the amount of healthy tissue that receives radiation without limiting our ability to cure cancers using radiation.
Head and Neck Cancer
Procedure: Align RT
||Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
||Comparison of Intrafraction Motion in Patients With Head and Neck Cancer Using Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking
Primary Outcome Measures:
- We are measuring how much a patient moves during treatment. [ Time Frame: This information will be available immediately have the patient is treated. ] [ Designated as safety issue: No ]
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||March 2010 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- Patients with HNC undergoing radiation therapy at Stanford University
- Age >= 18 years old
- Radiation course >= 4 weeks duration
- Ability to understand and the willingness to sign a written informed consent document.
- Factors such as claustrophobia inhibiting use of thermoplastic mask immobilization device.
- Patients who are pregnant or nursing, which preclude them from undergoing active radiation treatment.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01011842
|Stanford University School of Medicine
|Stanford, California, United States, 94305 |
Varian Medical Systems
No publications provided
||Quynh-Thu Le, Professor, Stanford University
History of Changes
|Other Study ID Numbers:
|Study First Received:
||November 9, 2009
||April 6, 2012
||United States: Institutional Review Board
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on November 27, 2014
Head and Neck Neoplasms
Neoplasms by Site